PDS Biotechnology Corp (PDSB) - היקף יתרות המזומנים של החברה

PDS Biotechnology relies on the Versamune ecosystem, which integrates oncology centers through strict trial protocols. The cash balance reflects current resource dynamics, where the 0.02 metric determines the liquidity parameter status. While demand for innovative vaccines remains independent of market cycles, negative cash flow and Phase 2 trials leave the company dependent on external financing.
פילוחים אנליטיים של חברת PDS Biotechnology

Automating vaccine development via the Versamune platform and AI requires significant capital expenditures, making liquidity monitoring critically important. This metric measures the volume of available cash on the balance sheet, allowing for an assessment of the solvency of PDS Biotechnology (PDSB) and the risk of business degradation in the absence of investment, which clearly reflects the change in cash levels.